Insiders · Profile

Shaw Christi

Director at Avantor · SVP and Pres., Lilly Bio-Meds at Lilly (Eli). Filing since 29 May 2018. CIK 0001702473

Company
Date
Role
Action
Shares
Amount
Of holding
11 Dec 2020
Director
Sold, plan not stated
14,286
$381.15K
55.8%
3 May 2019
SVP and Pres., Lilly Bio-Meds
Sold, plan not stated
7,577
$887.57K
100%
29 May 2018
SVP and Pres., Lilly Bio-Meds
Sold, plan not stated
8,426
$691.77K
100%
3 decisions on file.